Erythropoiesis-stimulating agents : development, detection and dangers

Saved in:
Bibliographic Details
Title translated into German:Erythropoetin-stimulierende Wirkstoffe : Entwicklung, Nachweis und Gefahren
Author:Franz, Stefan E.
Published in:Drug testing and analysis
Published:1 (2009), 6, S. 245-249, Lit.
Format: Publications (Database SPOLIT)
Publication Type: Journal article
Media type: Print resource
ISSN:1942-7603, 1942-7611
Online Access:
Identification number:PU201007005534

Author's abstract

Epoetin alfa, the first member of the family of erythropoiesis stimulating agents (ESAs), was introduced to the market in 1989. Since then development has progressed to epoetins of the third generation. Currently drugs that use alternative approaches to stimulate erythropoiesis are under development. Uptake of all available ESAs into doping has occurred rapidly after their introduction. A multitude of dangers to health are associated with the illicit use of these substances. Different approaches to detect ESAs in doping control have been developed to comply with the very diverse nature of the compounds used. Verf.-Referat